03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Unable to reach a last-minute deal with investors, rental car mainstay Hertz filed for bankruptcy la...
Read More >
The Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) requires parties to transactions meet...
Read More >
The U.S. Small Business Administration (SBA) recently published a list of frequently asked questions...
Read More >
The debate has raged for years. Is there a six-foot rule triggering fall protection requirements whe...
Read More >
On May 1, Mexico adopted sweeping changes to its labor laws, ushering in a new era of labor relation...
Read More >
In the course of managing a construction company, its projects and people, contractors, subcontracto...
Read More >